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Abstract
Arachnomelia is a monogenic recessive defect of skeletal development in cattle. The causative mutation was previously
mapped to a ,7 Mb interval on chromosome 5. Here we show that array-based sequence capture and massively parallel
sequencing technology, combined with the typical family structure in livestock populations, facilitates the identification of
the causative mutation. We re-sequenced the entire critical interval in a healthy partially inbred cow carrying one copy of
the critical chromosome segment in its ancestral state and one copy of the same segment with the arachnomelia mutation,
and we detected a single heterozygous position. The genetic makeup of several partially inbred cattle provides extremely
strong support for the causality of this mutation. The mutation represents a single base insertion leading to a premature
stop codon in the coding sequence of the SUOX gene and is perfectly associated with the arachnomelia phenotype. Our
findings suggest an important role for sulfite oxidase in bone development.
Citation: Dro ¨gemu ¨ller C, Tetens J, Sigurdsson S, Gentile A, Testoni S, et al. (2010) Identification of the Bovine Arachnomelia Mutation by Massively Parallel
Sequencing Implicates Sulfite Oxidase (SUOX) in Bone Development. PLoS Genet 6(8): e1001079. doi:10.1371/journal.pgen.1001079
Editor: Michel Georges, University of Lie `ge, Belgium
Received March 29, 2010; Accepted July 22, 2010; Published August 26, 2010
Copyright:  2010 Dro ¨gemu ¨ller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by grant no. 31003A_129651 from the Swiss National Science Foundation. The funder had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Tosso.Leeb@itz.unibe.ch
Introduction
Arachnomelia is a genetic disease in cattle characterized by
skeletal abnormalities. Affected calves are usually stillborn with a
spidery appearance and an abnormally shaped skull (Figure 1).
The bones of the limbs are prolonged (dolichostenomelia) with
marked thinning of the diaphyses that fracture easily in the
course of forced birth assistance. Additional dysmorphic features
are variable, e.g. defects of the vertebral column and sometimes
cardiac malformations [1–4]. Initially, it was assumed that the
pathogenesis of bovine arachnomelia resembles that of human
Marfan syndrome, which is caused by mutations in the FBN1
gene [1]. However, the identification of other cattle with a
mutation in the FBN1 gene established that arachnomelia is
phenotypically distinct from Marfan syndrome [5]. Arachnome-
lia affected calves lack some typical Marfan features such as joint
laxity and aortic root dilation [3]. Bovine arachnomelia is
inherited as a monogenic autosomal recessive trait with complete
penetrance [2,4]. Carrier animals do not present any clinical
signs. An outbreak of arachnomelia with hundreds of cases
occurred during the 1980s after extensive world-wide usage of a
highly selected artificial insemination sire in the international
Brown Swiss cattle population [2]. In the past few years, a
comparable outbreak of arachnomelia occurred in German
Fleckvieh cattle [4]. Different genes seem to be responsible for
the arachnomelia disease in these two cattle breeds, as there is no
relationship between the founder animals and recently two
independent loci were genetically mapped to different chromo-
somes [6,7]. We mapped the arachnomelia mutation in Brown
Swiss cattle to a 7.19 Mb interval on bovine chromosome (BTA)
5 [6]. Due to the lack of suitable candidates the genetic basis of
arachnomelia is not understood. Therefore, the spontaneous
cattle arachnomelia mutants provide unique resources to gain
further insights into the biology of bone development.
Array enrichment and next-generation sequencing technology
can be used to rapidly sequence targeted subsets of the genome
[8,9]. Sequence capture enrichment has already successfully been
used to sequence the coding portion of the human genome
[10–12] and also large genomic intervals [13,14]. This technology
offers great potential for positional cloning projects where the
mapping resolution may be limited, e.g. in the case of recent
mutations. Thus megabase sized regions can now be re-sequenced
efficiently. Furthermore, the unique family structures in livestock
populations greatly facilitate the discrimination of the causative
variant from the many neutral polymorphisms that have to be
expected from such re-sequencing projects. In this report we
applied this approach to identify the causative mutation for bovine
arachnomelia.
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We selected two individuals for an array-based sequence
capture and massively parallel sequencing approach to re-
sequence the entire critical interval. Our design included one
arachnomelia affected calf assumed to be homozygous across the
entire sequence interval including the causative variant. The other
animal chosen for re-sequencing was a partially inbred non-
affected cow. Based on pedigree and marker data this non-affected
cow was identical-by-descent for the critical segment of BTA 5,
except for the causative arachnomelia mutation, which we
predicted to reside only on her paternally derived chromosome
(Figure 2). We chose this cow for complete re-sequencing of the
entire critical interval, as the detection of a heterozygous
polymorphism in this animal should reveal the causative mutation.
We enriched the ,3.5 Mb non-repetitive sequence within the
critical interval of BTA 5 in the two animals and collected about
30 million illumina reads per animal. After the alignment to the
reference sequence, the mean coverage was 44-fold for the affected
animal and 15-fold for the non-affected animal. The difference
was most likely due to technical variations during the hybridiza-
tion. The depth of coverage was variable across the targeted
interval, similar to what had been described previously [15].
However, the two animals showed a similar distribution of the
gaps across the targeted interval (Figure S1). In the affected calf
96% of the enriched bases had at least 4-fold coverage compared
to 91% in the control sample. We called a homozygous variant
when the respective position had $4-fold coverage and the
observed difference between the experimental reads and the
reference sequence occurred at $75% frequency. For the calling
of a heterozygote variant we applied a threshold of $15-fold
sequence coverage and a variant allele frequency between 25%
and 75% based on published recommendations [16]. Using these
criteria we recovered a total of 6,025 putative variants between the
reads and the reference for the affected calf (4,848 homozygous
and 1,177 heterozygous), and 4,318 putative variants for the
control cow (3,818 homozygous and 500 heterozygous, Table 1).
The high number of seemingly heterozygous variants detected in
two animals supposed to be completely or almost completely
homozygous underscores the challenges of aligning short reads
from a complex mammalian genome to a draft quality reference
sequence. About three-fourths of the heterozygous variant calls
were located within an olfactory receptor (OR) gene cluster
encompassing a 2.2 Mb segment with a total of 136 annotated loci
[17]. The read coverage within this region was significantly higher
than the average (60/37-fold) indicating segmental duplications.
Other factors contributing to the high number of putative
heterozygous variants may have been sequencing errors, non-
specific hybridization of DNA during the enrichment, or
amplification-mediated artifacts (i.e. polymerase errors during
library preparation).
Due to the recessive inheritance and the lethal effect of the
mutation we hypothesized that most likely a loss of function
mutation affecting the coding sequence of a gene would be
responsible for arachnomelia. Therefore, we subsequently con-
centrated on variants that were located within the coding
sequences or within the splice sites of the annotated genes in the
targeted region of the bovine genome. A total of 79 predicted
homozygous variants were located within coding sequences or
adjacent splice sites of the affected calf (Table 1, Table S1). The
comparison between the affected calf and the non-affected cow
revealed that 68 of these variants had identical homozygous
mutant genotypes in the control cow and could thus be excluded
as causative variants. Eight variants had no illumina coverage in
the control cow and were subsequently found to be homozygous
mutant by Sanger sequencing and thus also excluded. The three
remaining variants were putative heterozygous variants in the
control cow with 10, 12, and 27-fold coverage, respectively. We
validated these three potential variants by Sanger sequencing and
found that two of them were false positives as the affected calf and
the control cow shared identical homozygous genotypes for these
variants. For the remaining variant we confirmed that the control
cow was indeed heterozygous, whereas the affected calf was
homozygous mutant compared to the reference sequence. This
variant was a 1 bp insertion located in exon 4 of the bovine SUOX
gene (c.363–364insG, Figure 3). We found perfect concordance
between the presence of this insertion and the arachnomelia
phenotype (Table 2). All 16 affected calves were homozygous
mutant and all 11 available mothers for these animals were
heterozygous. Genomic DNA samples of 25 artificial insemination
carrier sires, which had recorded arachnomelia offspring and
which were related to the assumed founder, were tested and 23 of
them were also heterozygous. For each of the two remaining
suspected carriers only one single arachnomelia suspicious calf was
recorded by the breeding organization and the diagnoses of these
calves had not been confirmed by veterinarians. Therefore, we
think that these two reported arachnomelia calves represented
phenocopies and their sires are indeed free of the arachnomelia
mutation. Our material included Beautician, son of the assumed
founder Lilason, who was responsible for spreading the mutation
into the global Brown Swiss population. We confirmed that
Beautician is heterozygous for the SUOX mutation supporting the
hypothesis for the origin of the causative mutation. Three
acknowledged carrier bulls, which had the same genetic
constellation as the non-affected inbred cow of our mutation
analysis and were homozygous for all tested markers in the critical
interval, were also found to be heterozygous for the SUOX
mutation (Figure S2). None of 309 unrelated healthy Brown Swiss
cattle had the homozygous mutant genotype, but 10 of them were
presumed carriers. Thus the allele frequency of the deleterious
insertion within this sample of unrelated Brown Swiss cattle was
1.6%, which is about half of the frequency that was estimated 20
Author Summary
Arachnomelia is a defect in skeletal development of cattle.
Affected calves are born dead with elongated limbs and
facial deformities. The causative mutation for this recessive
condition had previously been mapped to a ,7M b
interval. We exploited the special structure of cattle
families to identify the causative mutation by a purely
genetic approach. The rich pedigree records in cattle
breeding allowed us to identify the founder animal of
arachnomelia, a Brown Swiss bull born in 1957. A few
generations later several cattle received two copies of the
same chromosome segment from the father of this bull
due to inbreeding. One copy was passed through the
founder animal and acquired the causative mutation, while
the other copy was transmitted through a different line of
animals and stayed in its ancestral state. Using next-
generation sequencing, we sequenced the entire critical
interval in one of these inbred animals. As expected, we
found only one single heterozygous position, which
consequently represents the causative mutation for
arachnomelia. The mutation affects the gene for sulfite
oxidase, thus indicating a previously unrecognized impor-
tant role for this enzyme in bone development. Our
findings can immediately be applied to remove this
deleterious mutation from the cattle breeding population.
SUOX Gene in Bone Development
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from 15 breeds widely used in commercial cattle production to
confirm that the identified mutation does not occur outside the
Brown Swiss population. None of the 150 chromosomes in this
sample showed the causative insertion (Table 2).
The c.363–364insG insertion is predicted to result in a
frameshift beginning with amino acid residue 124 in the bovine
SUOX protein sequence (p.Ala124GlyfsX42). While it is unclear
whether the mutant protein of 164 residues is actually expressed,
with more than 75% of the normal SUOX protein missing, it is
very unlikely that the mutant protein fulfills any physiological
function. Due to the frameshift and the premature stop codon, any
mutant protein produced will contain 42 altered amino acids, and
could potentially interfere with normal cellular function. The
Figure 1. Phenotype of bovine arachnomelia in Brown Swiss cattle. (A,B) Stillborn affected calves; note the abnormal length of all legs
(dolichostenomelia), the angular deformities in the distal part of the hind legs with arthrogryposis of the distal joints, and a muscular atrophy of the
legs. (C,D) Typical facial deformities of affected calves; note a concave rounding of the dorsal profile of the maxilla and brachygnathia inferior. (E)
Radiography of the hind limbs of the affected calf from (C); note that the joint ends (epiphyses) of the long bones are of normal size but with marked
thinning of the shafts (diaphyses) showing increased fragility. (F) Radiography of the left hind leg of a non-affected control calf.
doi:10.1371/journal.pgen.1001079.g001
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terminal enzyme in the oxidative degradation pathway of sulfur-
containing amino acids. Each monomer of the dimeric SUOX
enzyme consists of three domains, the N-terminal heme domain,
the central molybdenum domain and a C-terminal domain [19].
Deficiency of this enzyme in humans usually leads to recessive
inherited sulfocysteinuria (OMIM 272300) characterized by major
neurological abnormalities and early death [19–22]. The more
severe cases, characterized by frequent seizures and death within a
few days of birth, result from a complete SUOX loss of function
[20,22]. A single case of human sulfocysteinuria caused by a 1 bp
deletion of human SUOX leading to a truncated protein has been
reported, where some dysmorphic skeletal features were diagnosed
in addition to severe neurodevelopmental anomalies [22].
The arachnomelia phenotype in cattle shows more severe
skeletal defects and neonatal lethality compared to the human
sulfocysteinuria patients. Another genetic disorder of human sulfur
metabolism associated with a bone phenotype (arachnodactyly) is
caused by CBS mutations resulting in cystathionine beta-synthase
deficiency [23].
In cattle there are two virtually identical arachnomelia
phenotypes in Brown Swiss cattle and in German Fleckvieh cattle.
The mutation in German Fleckvieh was mapped to BTA 23, a
region where the MOCS1 gene encoding molybdenum cofactor
synthesis 1 is located [7]. A candidate causative mutation for
German Fleckvieh arachnomelia has recently been identified in
the bovine MOCS1 gene [Johannes Buitkamp, personal commu-
nication]. The MOCS1 protein is required for the synthesis of the
molybdopterin cofactor, which forms the active site in SUOX.
The involvement of SUOX and MOCS1 in the same biochemical
pathway mutually supports the causality of these mutations in
Brown Swiss and German Fleckvieh cattle.
We think that we have established the causality of the SUOX
mutation for arachnomelia in Brown Swiss cattle based on the
following arguments: (1) the perfect association of the SUOX
mutation to the arachnomelia phenotype, (2) the obvious
functional impact of a frameshift mutation on the encoded
protein, (3) four non-affected inbred animals, which were
identical-by-descent for all tested markers across the critical
interval, were heterozygous at the SUOX mutation. The
recognition of these four inbred animals was a key element in
our discovery and illustrates the potential of livestock specific
population structures for genetic research. This study represents
one of the first successful applications of microarray-based
enrichment of megabase-sized genomic regions followed by
massively parallel sequencing to unravel the causative mutation
underlying a Mendelian trait. This technology significantly
reduces the time and resources required for mutation identification
by abrogating the need for high resolution genetic mapping and
thousands of Sanger sequencing reactions.
In summary, we have successfully applied a sequence capture
strategy to identify SUOX as the causative gene for bovine
arachnomelia, and thereby discovered an essential role for this
gene during bone development. The knowledge of the causative
mutation will allow direct genetic testing of Brown Swiss cattle and
the elimination of this fatal genetic disease from the breeding
population. This study highlights the enormous potential of




The bovine genome assembly Btau 4.0 was used for all analyses.
A custom tiling 385k sequence capture array targeting the
arachnomelia region (BTA 5, 57,285,788–64,478,535 bp) was
designed and manufactured by Roche NimbleGen. The reference
sequence contained 179 gaps with a total of 49,558 bp (0.7% of
the target sequence). The array was designed using NimbleGen’s
standard 15-mer frequency masking to minimize repeat content
within capture probes. The probe spacing, tiling overlap, and
probe length were determined using proprietary algorithms
(NimbleGen). For the sequence capture library construction a
total of 20 mg high-molecular weight genomic DNA was sheared
to yield approximately 400 bp fragments using an ultrasound
Figure 2. Pedigree of selected inbred Brown Swiss cattle. The
special structure of livestock families facilitates the mutation identifi-
cation: The bull Lilason (arrow) is the founder animal for arachnomelia.
Thus the arachnomelia mutation (indicated by an A) must have
occurred either in the germline of Larry or during the early embryonic
development of Lilason. Beneath the animals the two copies of BTA 5
are indicated. Black symbols represent the ancestral chromosome, on
which the mutation occurred. Gray symbols represent any other wild-
type copy of BTA 5. Due to the inbreeding loop, the cow Valbella has
inherited two copies of the same chromosome from her ancestor Larry.
Her paternal copy of the critical 7.19 Mb interval carries the
arachnomelia mutation, while her maternal copy is still in its ancestral
wild-type state. The BTA 5 haplotypes were confirmed by microsatellite
genotyping of available samples from Beautician, Leon, Amaranto,
Elegant, Collection, and Valbella [5].
doi:10.1371/journal.pgen.1001079.g002
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genomic DNA was polished and repaired using T4 DNA
polymerase and T4 PNK (Fermentas). Illumina adapters were
added to each genomic DNA sample using T4 DNA ligase
(Fermentas). Adapter ligated samples were purified and amplifi-
cation competency was assessed by PCR with primers comple-
mentary to the ligated adapters and finally evaluated by agarose
gel electrophoresis. Array hybridization was executed using an X1
mixer (Roche NimbleGen) and the NimbleGen Hybridization
System for 3 days at 42uC following the manufacturer’s
recommended conditions. Human Cot-1 DNA (Invitrogen/Life
Technologies) was used at a mass ratio of 5:1 vs. the library. Arrays
were washed using the recommended protocol (Roche NimbleGen
Arrays User’s Guide v2.0). The captured molecules were eluted
from the slides with elution reagent using a NimbleGen Elution
Station. Eluted molecules were dried by centrifugation under
vacuum, rehydrated and PCR amplified for 18 cycles with
Phusion polymerase (Finnzymes). Enrichment of samples was
assessed by quantitative PCR comparison to the same samples
prior to hybridization. Following evaluation by agarose electro-
phoresis and purification, the amplified capture libraries were
Table 1. Sequence variants identified by massively parallel sequencing.
Case Control Shared
Total variants 6,025 4,318 3,083
SNPs 5,151 3,827 2,841
Transitions 3,255 2,544 1,903
Transversions 1,896 1,283 938
InDels 874 491 242
Insertions 477 241 95
Deletions 397 250 147
Homozygous (variant freq. $75%; coverage $4) 4,848 3,818 2,972




Homozygous CDS/splice site (coverage $4) 79 63 76
Homozygous CDS/splice site (coverage 1-3) 5
Missing coverage CDS/splice site 8
b
Heterozygous CDS/splice site (coverage $10) 3
c
aMost of these heterozygous positions (case: 74.4%, control: 61.2%) are located in the region of the OR gene cluster, which represents only 31% of the target sequence.
bSanger re-sequencing revealed that these eight positions were all homozygous mutant.
cSanger re-sequencing revealed that only one of these three positions was a true heterozygous variant.
doi:10.1371/journal.pgen.1001079.t001
Figure 3. Mutation identification in the bovine SUOX gene.
Electropherograms of a wild-type control animal (A), a carrier cow (B),
and an arachnomelia affected calf (C) are shown. A single G insertion,
which was homozygous in all analyzed cases, is marked by an arrow.
The protein translation of the wild-type and mutant sequence is shown
above the electropherograms.
doi:10.1371/journal.pgen.1001079.g003
Table 2. Association of the 1 bp insertion with the
arachnomelia phenotype.
wt/wt wt/ins ins/ins




Unrelated healthy Brown Swiss cattle 299 10 -
Healthy control cattle from 15 other breeds 75 - -
Total 376 44 16
aParents of affected offspring were classified as carriers.
bThe affected offspring of these two animals were assumed to represent
phenocopies (see main text).
doi:10.1371/journal.pgen.1001079.t002
SUOX Gene in Bone Development
PLoS Genetics | www.plosgenetics.org 5 August 2010 | Volume 6 | Issue 8 | e1001079processed into sequencing libraries for the illumina GAII. A total
of 33,676,855/31,356,905 single reads of different length (36 or
76 bp) comprising 2,245,122,900/2,241,558,140 bases raw data
were produced for case and control, respectively.
Read mapping and variant calling
Repetitive elements of the 7.19 Mb genome sequence were
masked using the Repeatmasker software and a total of
3,542,013 bp single copy sequence was used as reference for
short read mapping. The SeqMan NGen v2.0 software (DNAS-
TAR) was used for assembly with a minimal match percentage of
97%, a minimal match size of 19 nt, and a maximal coverage of
200. A total number of 4,984,147/1,440,459 reads were
assembled for the case and the control, respectively. We required
a minimal coverage of 4-fold for variant detection and $75% of
the variant allele for calling a homozygous mutant genotype.
Variants falling within the first 10 nt adjacent of masked repetitive
sequences were excluded due to obvious alignment inconsistencies
(e.g. high coverage, probably due to incomplete masking at the
ends of repeats). The post-assembly processing of the variant data
was carried out using the R statistical software package [24].
Sanger re-sequencing
Some variants were genotyped by re-sequencing of targeted
PCR products using Sanger sequencing technology. PCR products
were amplified using AmpliTaqGold360Mastermix (Applied
Biosystems). PCR products were directly sequenced on an ABI
3730 capillary sequencer (Applied Biosystems) after treatment with
exonuclease I and shrimp alkaline phosphatase. Sequence data
were analyzed with Sequencher 4.9 (GeneCodes).
Supporting Information
Figure S1 Capture performance. In both samples .90% of the
bases in the capture target region had at least 4-fold coverage
(96% in the affected calf and 91% in the control). The non-
captured single copy sequence regions are shown as the proportion
of bases (in percent) per sliding 10 kb window. The distribution of
the capture gaps was very similar between our two samples. More
than 80% of gaps without sequence reads occurred in similar
regions of single copy sequence.
Found at: doi:10.1371/journal.pgen.1001079.s001 (0.03 MB PDF)
Figure S2 Pedigree of selected Brown Swiss cattle. The bull
Lilason (arrow) is the acknowledged founder animal for arachno-
melia. His son Beautician was extensively used as artificial
insemination sire and spread the deleterious mutation into the
international Brown Swiss population. Chromosome symbols
beneath the animals indicate that we analyzed their BTA 5
haplotypes by microsatellite markers. The ancestral BTA 5
haplotype, on which the arachnomelia mutation occurred, is
indicated in solid black. Any other BTA 5 haplotype is indicated in
gray. The arachnomelia mutation is denoted by the letter A. We
identified four inbred animals (underlined), which inherited both
of their BTA 5 haplotypes in the critical region from their ancestor
Larry. These animals were homozygous for all tested markers
across the critical interval with the exception of the SUOX c.363-
364insG mutation.
Found at: doi:10.1371/journal.pgen.1001079.s002 (0.03 MB PDF)
Table S1 Details on the 79 coding polymorphisms.
Found at: doi:10.1371/journal.pgen.1001079.s003 (0.04 MB
XLS)
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